DRI Healthcare Trust · TSX:DHT.U
DRI Healthcare Trust — Q3 2026 Earnings Presentation
14 slides from DRI Healthcare Trust's earnings presentation, Nov 5, 2026
Slide 1: Advancing Science in the Pharmaceutical and Biotechnology Sector
Advancing Science in the Pharmaceutical and Biotechnology Sector Third Quarter 2026 Earnings Call |November 5, 2026 1
Slide 2: Disclaimer
Disclaimer This presentation has been prepared by DRI Healthcare Trust (“DRI Healthcare”). Established as an unincorporated open-ended trust in Ontario, Canada, and publicly trading since its 2021 IPO, DRI Healthcare is a global leader in providing financing to advance innovation in the life science
Slide 3: Ali Hedayat, Chief Executive Officer
Ali Hedayat Chief Executive Officer DRI Healthcare 3
Slide 4: Agenda
Agenda Ali Hedayat CEO Recent Highlights Navin Jacob Portfolio Update All Q&A CIO Zaheed Mawani CFO Financial Update 4
Slide 5: Recent Highlights
Recent Highlights Portfolio Recent Unitholder Performance Events Value • Cash receipts and Adjusted EBITDA • Monetized Ekterly for ~$178 million: • With Juvmo, current portfolio each up 9% YoY; 89% YTD margin 1.5x return in two years positioned to hit or exceed 2030 Adjusted EBITDA aspirations befor
Slide 6: Navin Jacob, Chief Investment Officer
Navin Jacob Executive Vice President, Investments & Chief Investment Officer, DRI Healthcare 6
Slide 7: Portfolio Performance
Portfolio Performance Portfolio assets show continued growth (millions of U.S. dollars) Q3 2026 Q3 2025 % Change¹ Q2 2026 % Change¹ TOTAL CASH ROYALTY RECEIPTS² $47.5 $43.6 9% $46.5 2% Casgevy - - n/a - n/a Ekterly³ 2.0 - n/a 2.2 (9) Empaveli / Syfovre 2.2 1.7 29 0.1 n/m Eylea 1.2 1.5 (19) 1.2 (1) O
Slide 8: Robust pipeline of over $4.5 billion in potential opportunities
Address important unmet needs with life-changing therapies for patients Robust pipeline of over $4.5 billion Marketed by leading biotech or biopharma companies in potential opportunities1 Provides strong intellectual property and regulatory protection 1. As of September 30, 2026. Represents the aggr
Slide 9: Zaheed Mawani, Chief Financial Officer
Zaheed Mawani Chief Financial Officer 9
Slide 10: Q3 2026 Financial Highlights
Q3 2026 Financial Highlights Normalized Total Cash Receipts1 Total income Adjusted EBITDA1 $47.5 million $46.9 million $40.0 million 9% vs. Q3 2025 4% vs. Q3 2025 9% vs. Q3 2025 Adjusted EBITDA Margin1 Adjusted Cash Earnings per Unit1 Declared Cash Distributions per Unit 84% $0.53 $0.11 1. Normalize
Slide 11: Strong Cash Generation
Strong Cash Generation Cash available to drive portfolio growth and maintain distributions to Unitholders Adjusted EBITDA1 for the Last Twelve Months Ended September 30, 2026 (millions) LTM Adjusted EBITDA Margin1 $207.2 ($2.1) ($0.8) ($0.5) 90% ($0.9) $202.9 ($21.3) $181.6 Total Income Net gain (lo
Slide 12: Well-Capitalized for Growth
Well-Capitalized for Growth Significant capacity for Cash and Royalties Credit facility cash equivalents receivable availability further $41.1 $53.3 $349.0 growth million1 million1 million1 1. As at September 30, 2026. 12
Slide 13: Key priorities
Efficient Execution & Disciplined Expense Management Key priorities Strengthening Asset Risk Framework Disciplined Capital Allocation Focus on long-term, sustainable growth generating strong Unitholder returns 13
Slide 14: Thank you
Thank you Contact us Katherine Rebejko ir@drihealthcare.com 14